Drug Profile


Alternative Names: B Cell lymphoma vaccine - Genitope; MyVax

Latest Information Update: 16 Aug 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Genitope Corporation
  • Class Cancer vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Chronic lymphocytic leukaemia; Lymphoma

Most Recent Events

  • 16 Apr 2008 Final efficacy data from a phase III trial in Follicular Non-Hodgkin's lymphoma presented at the 99th Annual Meeting of the American Association for Cancer Research (AACR-2008)
  • 11 Mar 2008 Suspended - Phase-I/II for Chronic lymphocytic leukaemia in USA (SC)
  • 11 Mar 2008 Suspended - Phase-III for Lymphoma in Canada (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top